Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82170872, 92057116)
  • Chinese Academy of Sciences (XDA12040328)
  • Science and Technology Commission of Shanghai Municipality (20S11903400)
  • Natural Science Foundation of Shanghai Municipality (21ZR1475300)

This publication has 55 references indexed in Scilit: